Company: BGLC
Filing Date: 2025-02-28
Form Type: DEFR14A
Source: 0001477932-25-001339
Chunk: 2

Company: BioNexus Gene Lab Corp
Filing Date: 2025-02-28
Form: DEFR14A
Chunk 2
---
2025 |

Important Notice Regarding the Availability of Proxy Materials for the Special Meeting of Stockholders to be Held on March 19, 2025: Pursuant to the rules of the Securities and Exchange Commission, with respect to the Special Meeting, we have elected to utilize the “full set delivery” option of providing paper copies of all of our proxy materials by mail. The Notice of Special Meeting of Stockholders and Proxy Statement are also available at https://onlineproxyvote.com/BGLC/2025.

Whether or not you expect to participate in the Special Meeting, please vote via the Internet, by phone, or complete, date, sign and promptly return the accompanying proxy card or voting instruction card in the enclosed postage-paid envelope so that your shares may be represented at the Special Meeting. If you attend the Special Meeting online and vote your shares at that time, your proxy will not be used.

| 2 |

<div align='center'>BIONEXUS GENE LAB CORP.

PROXY STATEMENT

SPECIAL MEETING OF STOCKHOLDERS

To Be Held On March 19, 2025

TABLE OF CONTENTS</div>

| Information about the Special Meeting and Voting               |     |       4 |
| Matters To Be Considered At Special Meeting                    |     |       8 |
| Proposal 1: Reverse Stock Split Proposal                       |     |       8 |
| Proposal 2: Adjournment Proposal                               |     |      18 |
| Security ownership of certain beneficial owners and management |     |      19 |
| Householding of Proxy Materials                                |     |      20 |
| Other Matters                                                  |     |      20 |
| Where You Can Find Additional Information                      |     |      20 |
| Form of Reverse Stock Split Charter Amendment                  |     | Annex A |

<div align='center'>Forward-Looking Statements</div>

This proxy statement (this “Proxy Statement”) contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this Proxy Statement that do not relate to matters of historical fact should be considered forward-looking statements, including without limitation statements regarding the Company’s intent or ability to effect a reverse stock split or to regain compliance with any applicable Nasdaq listing requirements. These statements are based on management’s current assumptions and are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause the Company’s actual results, performance or achievements to be materially different from any future